Editorial: gut microbiota profile in patients with autoimmune hepatitis-a clue for adjunctive probiotic therapy?
- PMID: 32592252
- DOI: 10.1111/apt.15795
Editorial: gut microbiota profile in patients with autoimmune hepatitis-a clue for adjunctive probiotic therapy?
Comment in
-
Editorial: gut microbiota profile in patients with autoimmune hepatitis-a clue for adjunctive probiotic therapy? Authors' reply.Aliment Pharmacol Ther. 2020 Jul;52(2):394-395. doi: 10.1111/apt.15819. Aliment Pharmacol Ther. 2020. PMID: 32592249 No abstract available.
Comment on
-
A disease-specific decline of the relative abundance of Bifidobacterium in patients with autoimmune hepatitis.Aliment Pharmacol Ther. 2020 Jun;51(12):1417-1428. doi: 10.1111/apt.15754. Epub 2020 May 7. Aliment Pharmacol Ther. 2020. PMID: 32383181
References
REFERENCES
-
- Zachou K, Muratori P, Koukoulis GK, et al. Review article: autoimmune hepatitis - current management and challenges. Aliment Pharmacol Ther. 2013;38:887-913.
-
- Ferri S, Longhi MS, De Molo C, et al. A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis. Hepatology. 2010;52:999-1007.
-
- Adolph TE, Grander C, Moschen AR, et al. Liver-microbiome axis in health and disease. Trends Immunol. 2018;39:712-723.
-
- Tripathi A, Debelius J, Brenner DA, et al. The gut-liver axis and the intersection with the microbiome. Nat Rev Gastroenterol Hepatol. 2018;15:397-411.
-
- Wei Y, Li Y, Yan LI, et al. Alterations of gut microbiome in autoimmune hepatitis. Gut. 2020;69:569-577.